(Q40521478)

21 September 2017

An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy (English)

1 reference

21 September 2017

1 reference

Ningxi Zhu

1

1 reference

21 September 2017

Lubing Gu

2

1 reference

21 September 2017

Harry W Findley

3

1 reference

21 September 2017

Fengzhi Li

4

1 reference

21 September 2017

Muxiang Zhou

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

7545-7551

1 reference

21 September 2017

45

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208038

21 September 2017

0 references

cites work

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

Control of apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Differential subcellular localization of functionally divergent survivin splice variants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Induction and alternative splicing of the Bax gene mediated by p53 in a transformed endothelial cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208038

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208038

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference